Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Cancer Occurrence and Outcome in Young Patients Undergoing Cancer Treatment at the Vanderbilt-Ingram Cancer Center

This study has been terminated.
Sponsor:
Collaborator:
Information provided by:
Vanderbilt University
ClinicalTrials.gov Identifier:
NCT00670605
First received: May 1, 2008
Last updated: March 23, 2011
Last verified: March 2011
  Purpose

RATIONALE: Gathering information about the number of young patients with cancer and the outcome of these patients may help doctors learn more about cancer.

PURPOSE: This research study is looking at the medical records of young patients undergoing cancer treatment at the Vanderbilt-Ingram Cancer Center to determine how often cancer occurs and the outcome of these patients.


Condition Intervention
Unspecified Adult Solid Tumor, Protocol Specific
Unspecified Childhood Solid Tumor, Protocol Specific
Other: medical chart review
Other: study of socioeconomic and demographic variables

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: VICC Adolescent and Young Adult Oncology Review

Resource links provided by NLM:


Further study details as provided by Vanderbilt University:

Primary Outcome Measures:
  • Number of patients with newly diagnosed cancer from 1990 to 2005 and treated at Vanderbilt-Ingram Cancer Center (VICC), in middle Tennessee, and the state of Tennessee [ Designated as safety issue: No ]
  • Comparison of outcomes [ Designated as safety issue: No ]
  • Number of patients enrolled in clinical trials at VICC [ Designated as safety issue: No ]
  • Outcomes of patients treated on a trial vs those not treated with the same disease [ Designated as safety issue: No ]
  • Comparison of number of patients treated at Vanderbilt Children's Hospital vs Vanderbilt University Hospital [ Designated as safety issue: No ]
  • Referral patterns [ Designated as safety issue: No ]
  • Reason for not enrolling on a clinical trial [ Designated as safety issue: No ]

Study Start Date: June 2007
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Detailed Description:

OBJECTIVES:

  • To determine the number of patients between 15 and 30 years old who are treated for newly diagnosed cancer at the Vanderbilt-Ingram Cancer Center (VICC), in middle Tennessee, and in the state of Tennessee between 1990 and 2005.
  • To determine the outcomes of these patients.
  • To determine the number of these patients enrolled on clinical trials at VICC.
  • To compare the outcomes of these patients when treated on a trial versus not treated on a trial provided they have the same disease.
  • To compare the number of these patients who are treated on a clinical trial when they are first seen at Vanderbilt Children's Hospital vs Vanderbilt University Hospital.
  • To determine referral patterns of these patients to VICC.
  • To compare the outcomes of these patients who are treated at VICC vs middle Tennessee vs the state of Tennessee vs the entire nation.
  • To determine the reason for not enrolling on a clinical trial.

OUTLINE: Cancer cases taken from the Vanderbilt-Ingram Cancer Center (VICC) Registry and the Tennessee Cancer Registry are examined for number and types of cancer, mortality rates broken down by county and health department region, electronic medical records, and treatment outcomes. Data is analyzed for comparison of number of new cancer patients, mortality rates, and referral patterns at VICC versus number of new cancer patients in the region, state, and country.

  Eligibility

Ages Eligible for Study:   15 Years to 30 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Newly diagnosed

Criteria

DISEASE CHARACTERISTICS:

  • Diagnosis of cancer

    • Newly diagnosed disease from 1990 to 2005
    • 15 to 30 years old at the time of cancer diagnosis
  • Must live in the state of Tennessee

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • Not specified
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00670605

Locations
United States, Tennessee
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States, 37232-6838
Vanderbilt-Ingram Cancer Center - Cool Springs
Nashville, Tennessee, United States, 37064
Vanderbilt-Ingram Cancer Center at Franklin
Nashville, Tennessee, United States, 37064
Sponsors and Collaborators
Vanderbilt University
Investigators
Study Chair: Anderson B. Collier, MD Vanderbilt Children's Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00670605     History of Changes
Other Study ID Numbers: CDR0000584244, P30CA068485, VU-VICC-PED-0732, VU-VICC-070568
Study First Received: May 1, 2008
Last Updated: March 23, 2011
Health Authority: United States: Federal Government

Keywords provided by Vanderbilt University:
unspecified adult solid tumor, protocol specific
unspecified childhood solid tumor, protocol specific

Additional relevant MeSH terms:
Neoplasms

ClinicalTrials.gov processed this record on November 25, 2014